| Jung Duk Oh, MD,PHD | |
|
6501 Loisdale Court, Springfield, VA 22150 | |
| (703) 922-1313 | |
| (703) 922-1111 |
| Full Name | Jung Duk Oh |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 17 Years |
| Location | 6501 Loisdale Court, Springfield, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710108345 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lourdes Hospital | Binghamton, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Our Lady Of Lourdes Memorial Hospital Inc | 1254237779 | 226 |
News Archive
BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.
Nearly 40 percent of the small adrenal tumors that cause big problems with high blood pressure share a genetic mutation that causes patients to retain too much sodium, researchers report.
Following a California Institute for Regenerative Medicine Independent Citizens Oversight Committee meeting held last week, University of California, Irvine researchers learned they will receive $6 million in funding to support the continued development of a promising new treatment for Huntington's disease
Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American Urological Association Annual Meeting in San Francisco, May 29 to June 3.
› Verified 8 days ago
| Entity Name | Our Lady Of Lourdes Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629087580 PECOS PAC ID: 1254237779 Enrollment ID: O20031208000366 |
News Archive
BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.
Nearly 40 percent of the small adrenal tumors that cause big problems with high blood pressure share a genetic mutation that causes patients to retain too much sodium, researchers report.
Following a California Institute for Regenerative Medicine Independent Citizens Oversight Committee meeting held last week, University of California, Irvine researchers learned they will receive $6 million in funding to support the continued development of a promising new treatment for Huntington's disease
Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American Urological Association Annual Meeting in San Francisco, May 29 to June 3.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jung Duk Oh, MD,PHD 6501 Loisdale Court, Springfield, VA 22150 Ph: (703) 922-1313 | Jung Duk Oh, MD,PHD 6501 Loisdale Court, Springfield, VA 22150 Ph: (703) 922-1313 |
News Archive
BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.
Nearly 40 percent of the small adrenal tumors that cause big problems with high blood pressure share a genetic mutation that causes patients to retain too much sodium, researchers report.
Following a California Institute for Regenerative Medicine Independent Citizens Oversight Committee meeting held last week, University of California, Irvine researchers learned they will receive $6 million in funding to support the continued development of a promising new treatment for Huntington's disease
Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American Urological Association Annual Meeting in San Francisco, May 29 to June 3.
› Verified 8 days ago
Dr. Lynn A Daltner, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5510 Alma Ln, Springfield, VA 22151 Phone: 703-642-5990 Fax: 703-642-5003 | |
Amandeep Singh, PA Gastroenterology Medicare: Medicare Enrolled Practice Location: 6128 Brandon Ave Ste 208-210, Springfield, VA 22150 Phone: 301-659-0003 Fax: 301-829-7694 | |
Anita Banerjee, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5514 Alma Ln, Ste 200, Springfield, VA 22151 Phone: 703-563-1575 | |
Arehzo Jahangiri, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6136 Brandon Ave, Springfield, VA 22150 Phone: 703-866-3131 | |
Dr. Walter W Immel, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5510 Alma Ln, Springfield, VA 22151 Phone: 703-642-5990 Fax: 703-642-5003 | |
Dr. Allen S. Gardner, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6128 Brandon Ave Ste 201, Springfield, VA 22150 Phone: 703-780-2800 Fax: 703-780-0461 | |
Dr. Margaret E Fisher, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6501 Loisdale Court, Springfield, VA 22150 Phone: 703-922-1407 Fax: 703-922-1111 |